Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-17,100
Closed -$934K 1149
2020
Q4
$934K Sell
17,100
-11,600
-40% -$610K ﹤0.01% 811
2020
Q3
$1.44M Sell
28,700
-75,000
-72% -$3.56M 0.01% 470
2020
Q2
$3.96M Buy
+103,700
New +$3.33M 0.03% 332
2020
Q1
Sell
-201,180
Closed -$8.15M 829
2019
Q4
$8.15M Buy
201,180
+162,443
+419% +$6.63M 0.05% 318
2019
Q3
$1.65M Sell
38,737
-241,286
-86% -$10.1M 0.01% 519
2019
Q2
$13.8M Buy
+280,023
New +$14.2M 0.11% 178
2019
Q1
Sell
-27,726
Closed -$1.7M 854
2018
Q4
$1.7M Buy
+27,726
New +$1.87M 0.01% 445
2018
Q3
Sell
-3,920
Closed -$307K 930
2018
Q2
$307K Buy
3,920
+310
+9% +$24K ﹤0.01% 758
2018
Q1
$266K Sell
3,610
-2,972
-45% -$211K ﹤0.01% 769
2017
Q4
$449K Sell
6,582
-1
-0% -$65 ﹤0.01% 617
2017
Q3
$405K Buy
6,583
+593
+10% +$36.4K ﹤0.01% 769
2017
Q2
$376K Sell
5,990
-1,869
-24% -$107K ﹤0.01% 577
2017
Q1
$436K Buy
+7,859
New +$405K 0.01% 550

Other funds holding NUS

Natixis's NUS Position: Q1 2021 in Review

Natixis sold out of Nu Skin (NUS) in Q1 2021, closing a stake of 17,100 shares — an estimated $934K sold.

Natixis first reported a position in NUS in Q1 2017 and held it in 13 quarters. The position peaked at $13.8M in Q2 2019. 276 funds tracked by Wall St. Rank hold NUS as of Q1 2021.

  • Natixis reported no remaining Nu Skin position as of Q1 2021 after selling out during the quarter.
  • Natixis sold 17,100 Nu Skin shares in Q1 2021, an estimated $934K.
  • Natixis first reported a position in Nu Skin in Q1 2017 and held it in 13 quarters.
  • Natixis's Nu Skin position peaked at $13.8M in Q2 2019.
  • 276 funds tracked by Wall St. Rank held Nu Skin as of Q1 2021.

Based on Natixis's 13F filing for Q1 2021, filed 14 May 2021.